Cyclopharm Raises AU$14 Million via Placement; Shares Fall 17%

MT Newswires Live

Feb 04

Cyclopharm (ASX:CYC) raised AU$14 million via a two-tranche placement of 14.7 million new shares at AU$0.95 per share to new and existing institutional, sophisticated, and professional investors, according to a Wednesday filing with the Australian bourse.

The company will issue 9.5 million shares on Feb.11, followed by 5.3 million shares on Feb.25, the filing said.

Additionally, the company plans to undertake a share purchase plan at the same price to raise a further AU$2 million, the filing added.

Funds raised will be used to advance the commercial rollout of Technegas in the US, the company said.

The new shares under the second tranche of the placement are expected to settle on Feb. 24.

Shares of the company fell 17% in recent Wednesday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2608433329"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2608433329\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2608433329?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 10:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608433329","market":"hk","top_or_hot":-1,"title":"Cyclopharm Raises AU$14 Million via Placement; Shares Fall 17%","media":"MT Newswires Live","content":"<html><body><p> Cyclopharm (ASX:CYC) raised AU$14 million via a two-tranche placement of 14.7 million new shares at AU$0.95 per share to new and existing institutional, sophisticated, and professional investors, according to a Wednesday filing with the Australian bourse.</p><p>The company will issue 9.5 million shares on Feb.11, followed by 5.3 million shares on Feb.25, the filing said.</p><p>Additionally, the company plans to undertake a share purchase plan at the same price to raise a further AU$2 million, the filing added.</p><p>Funds raised will be used to advance the commercial rollout of Technegas in the US, the company said.</p><p>The new shares under the second tranche of the placement are expected to settle on Feb. 24.</p><p>Shares of the company fell 17% in recent Wednesday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cyclopharm Raises AU$14 Million via Placement; Shares Fall 17%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCyclopharm Raises AU$14 Million via Placement; Shares Fall 17%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-02-04 10:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Cyclopharm (ASX:CYC) raised AU$14 million via a two-tranche placement of 14.7 million new shares at AU$0.95 per share to new and existing institutional, sophisticated, and professional investors, according to a Wednesday filing with the Australian bourse.</p><p>The company will issue 9.5 million shares on Feb.11, followed by 5.3 million shares on Feb.25, the filing said.</p><p>Additionally, the company plans to undertake a share purchase plan at the same price to raise a further AU$2 million, the filing added.</p><p>Funds raised will be used to advance the commercial rollout of Technegas in the US, the company said.</p><p>The new shares under the second tranche of the placement are expected to settle on Feb. 24.</p><p>Shares of the company fell 17% in recent Wednesday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CYC.AU","symbol_name":"CYCLOPHARM LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2608433329","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2608433329","pubTimestamp":1770173416,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cyclopharm  raised AU$14 million via a two-tranche placement of 14.7 million new shares at AU$0.95 per share to new and existing institutional, sophisticated, and professional investors, according to a Wednesday filing with the Australian bourse.The company will issue 9.5 million shares on Feb.11, followed by 5.3 million shares on Feb.25, the filing said.Additionally, the company plans to undertake a share purchase plan at the same price to raise a further AU$2 million, the filing added.Funds raised will be used to advance the commercial rollout of Technegas in the US, the company said.The new shares under the second tranche of the placement are expected to settle on Feb. 24.Shares of the company fell 17% in recent Wednesday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CYC.AU":"CYCLOPHARM LTD","BK7007":"医疗保健设备"},"translate_title":"Cyclopharm通过配售筹集1400万澳元；股价下跌17%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CYC.AU":1},"content_text":"Cyclopharm (ASX:CYC) raised AU$14 million via a two-tranche placement of 14.7 million new shares at AU$0.95 per share to new and existing institutional, sophisticated, and professional investors, according to a Wednesday filing with the Australian bourse.The company will issue 9.5 million shares on Feb.11, followed by 5.3 million shares on Feb.25, the filing said.Additionally, the company plans to undertake a share purchase plan at the same price to raise a further AU$2 million, the filing added.Funds raised will be used to advance the commercial rollout of Technegas in the US, the company said.The new shares under the second tranche of the placement are expected to settle on Feb. 24.Shares of the company fell 17% in recent Wednesday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}